ATE457316T1 - Polypeptide zur diagnose und therapie von leishmaniasen - Google Patents

Polypeptide zur diagnose und therapie von leishmaniasen

Info

Publication number
ATE457316T1
ATE457316T1 AT03780614T AT03780614T ATE457316T1 AT E457316 T1 ATE457316 T1 AT E457316T1 AT 03780614 T AT03780614 T AT 03780614T AT 03780614 T AT03780614 T AT 03780614T AT E457316 T1 ATE457316 T1 AT E457316T1
Authority
AT
Austria
Prior art keywords
seq
indian
leishmania
strains
polypeptides
Prior art date
Application number
AT03780614T
Other languages
English (en)
Inventor
Sarman Singh
Ramu Sivakumar
Original Assignee
All India Inst Med
Dept Of Biotechnology India
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by All India Inst Med, Dept Of Biotechnology India filed Critical All India Inst Med
Application granted granted Critical
Publication of ATE457316T1 publication Critical patent/ATE457316T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03780614T 2003-12-26 2003-12-26 Polypeptide zur diagnose und therapie von leishmaniasen ATE457316T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000400 WO2005063803A1 (en) 2003-12-26 2003-12-26 Polypeptides for the diagnosis and therapy of leishmaniasis

Publications (1)

Publication Number Publication Date
ATE457316T1 true ATE457316T1 (de) 2010-02-15

Family

ID=34717534

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03780614T ATE457316T1 (de) 2003-12-26 2003-12-26 Polypeptide zur diagnose und therapie von leishmaniasen

Country Status (9)

Country Link
US (1) US7740859B2 (de)
EP (1) EP1711520B1 (de)
CN (1) CN100480265C (de)
AT (1) ATE457316T1 (de)
AU (1) AU2003288711A1 (de)
BR (1) BR0318688A (de)
DE (1) DE60331266D1 (de)
ES (1) ES2345046T3 (de)
WO (1) WO2005063803A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010577A1 (en) * 2008-07-25 2010-01-28 Department Of Biotechnology Constructing a dna chimera for vaccine development against leishmaniasis and tuberculosis
CN102590508A (zh) * 2012-03-12 2012-07-18 中国疾病预防控制中心寄生虫病预防控制所 检测亲内脏利什曼原虫感染和诊断黑热病的免疫层析试条
WO2016055836A1 (pt) * 2014-10-09 2016-04-14 Universidade Federal De Minas Gerais - Ufmg Processo de produção e uso da proteína rk39-kddr e kit para diagnóstico de leishmaniose
US20250020642A1 (en) * 2021-10-28 2025-01-16 Vida Pharmacal Inc. Method and antigen composition for rapid detection of chagas disease, leishmaniasis, and/or heartworm in humans and animals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411865A (en) * 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies
US5912166A (en) 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US5834592A (en) 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6855522B2 (en) 2002-02-27 2005-02-15 Indian Council Of Medical Research Species-specific PCR assay for detection of Leishmania donovani in clinical samples of kala-azar and post kala-azar dermal leishmaniasis

Also Published As

Publication number Publication date
EP1711520B1 (de) 2010-02-10
US7740859B2 (en) 2010-06-22
ES2345046T3 (es) 2010-09-14
EP1711520A1 (de) 2006-10-18
BR0318688A (pt) 2006-12-19
AU2003288711A1 (en) 2005-07-21
US20080031878A1 (en) 2008-02-07
WO2005063803A1 (en) 2005-07-14
CN1910197A (zh) 2007-02-07
CN100480265C (zh) 2009-04-22
DE60331266D1 (de) 2010-03-25

Similar Documents

Publication Publication Date Title
Liu et al. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
DE69922261D1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
DE60202877D1 (de) Gezieltes antikörper-verfahren
Cheng et al. Characterization of a novel merozoite surface protein of Plasmodium vivax, Pv41
Costa et al. New serological tools for improved diagnosis of human tegumentary leishmaniasis
Ohta et al. Research on calpain of Schistosoma japonicum as a vaccine candidate
DE60331266D1 (de) Polypeptide zur diagnose und therapie von leishmaniasen
CN105388300B (zh) 结核病免疫诊断分子标识及其疫苗用途
Shin et al. Comparison of proteome and antigenic proteome between two Neospora caninum isolates
WO2004020609A3 (en) Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
Iraqi Diagnostic value of semi-purified antigens of hydatid cyst fluid in human cystic echinococcosis
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
US10197577B2 (en) Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines
Hiltke et al. Characterization of a novel lipoprotein expressed by Haemophilus ducreyi
WO2010108245A3 (pt) Uso de antígenos de leishmania em método diagnóstico, vacina e terapia para leishmaniose
de Pádua Vidigal et al. Enzyme immunoassay using Leishmania (Viannia) braziliensis antigens for laboratorial diagnosis of American cutaneous leishmaniasis
CA2540736A1 (en) Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
WO2003080839A3 (en) Antigen fragments for the diagnosis of toxoplasma gondii
AU2018217443B2 (en) Hybrid peptide, set of hybrid peptides, composition, uses of the hybrid peptide, method for inducing an immune response and kits
ATE256704T1 (de) Antikörper und diagnostizierverfahren zur pestivirusdiagnose
Streeton et al. 211-PA10 QuantiFERON-TB: a new in vitro test for tuberculosis and atypical mycobacterial infection
Jawaharlal et al. Repeat region of Brugia malayi sheath protein (Shp-1) carries Dominant B epitopes recognized in filarial endemic population
Okaa et al. Endoglucanase-2 (Eng2), a conserved immunodominant antigen in dimorphic fungi that elicits immunity and resistance during infection
US20110104064A1 (en) Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals
Lee et al. Seropositivity and identification of paramyosin for sparganosis in the Kangwon and Incheon provinces of the Republic of Korea

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties